Professional Designation Faculty member, Chief of Department
Department Thoracic Surgery
Organization of Employment Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty
Degrees MD, PhD, FETCS

Profile

Professor Akif Turna graduated from Istanbul University Istanbul Medical School. He has been trained in thoracic surgery at Yedikule Teaching Hospital for Chest Diseases and Thoracic Surgery. He started VATS lobectomy program in 2007, received national and European Thoracic Surgery Board Certificates. 

He received his PhD in Immunology in 2003. 

He became a professor of thoracic surgery in Istanbul University-Cerrahpasa in 2013.  

He has been serving as a chief of Thoracic Surgery at Cerrahpasa School of Medicine.

He has a strong interest in minimally invasive thoracic surgery particularly uniportal VATS and RATS resections, mediastinal staging procedures, VAMLA, inflammatory and infectious diseases, surgery for emphysema, anti-tumor immunology and molecular biology of cancer.

Education

  • Istanbul University Istanbul Medical School
  • Yedikule Teaching Hospital for Chest Diseases and Thoracic Surgery

Recent & Current Appointments and Committee Memberships

  • Deputy Chief of Surgery
  • Managing Editor of Turkish Journal of Immunology
  • Section Editor of Asian Cardiovascular and Thoracic Annals
  • Associate Editor of Euroasian Journal of Pneumology

Research Interests

  • Minimally invasive surgery, staging for lung cancer, 
  • Anti-lung cancer immunity and Breg cells, 
  • AI in thoracic surgery

  •  ASCVTS-2024- Furuse Award
  •  Best abstract award: National Thoracic Surgery Congress; 2019
  •  Best abstract award: Turkish Society of Respiratory Research, 2022
  •  Best abstract award: Turkish Society of Lung Cancer, 2019

  • 2024, Trybalski Ł, Szadurski J, Zhang L, Kużdżał J, Turna A, Wang WD, Warmus J, Isık GO, Żanowska K, Kocoń P.Prevalence and quantity of lymph nodes at mediastinal stations in patients with lung cancer: lessons from 181 bilateral mediastinal lymphadenectomies. J Cardiothorac Surg. doi: 10.1186/s13019-024-02928-z.
  • 2024, Kılıç B, Sağlam ÖF, Chikvaidzade L, Erşen E, Kara HV, Turna A, Kaynak K, Demirkaya A Outcomes of minimally invasive surgery for pulmonary metastasis: who benefits the most? .Wideochir Inne Tech Maloinwazyjne. doi: 10.5114/wiitm.2024.140300.
  • 2024, STARSurg Collaborative; EuroSurg Collaborative Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe. Anaesthesia doi: 10.1111/anae.16324.
  • 2024, NIHR Global Health Research Unit on Global Surgery; STARSurg Collaborative. A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts. Lancet Digit Health. doi: 10.1016/S2589-7500(24)00065-7.
  • 2024, Sarbay I, Turna A. A case report of subconjunctival emphysema as a rare complication of pulmonary resections. J Minim Access Surg. doi: 10.4103/jmas.jmas_248_22

  • Study Of The Role Of Innate Lymphoid Cell Group 2 (ILC2) On CD4+ T Cells In The Microenvironment Of Non Small Cell Lung Cancer  
  • Identification Of The Cytokine Profile Of Innate Lymphoid Cell Group 2 (ILC2) In The Tumor Microenvironment (TME) Of Non-Smamm Cell Lung Cancer
  • Influence of bilateral mediastinal lymph node dissection on survival in non-small cell lung cancer patients – Randomized study
  • The Role of Tumor Infiltrating and Circulating Tumor Cells on Survival in Patients with Non-Small Cell Lung Cancer